DiaMedica Therapeutics Inc. Basic Shares Outstanding (Weighted Average)
DiaMedica Therapeutics Inc. (DMAC) reported Basic Shares Outstanding (Weighted Average) of 53.89 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- DiaMedica Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 53.89M shares, a 25.46% increase year-over-year.
- DiaMedica Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 53.79M shares, a 25.56% increase year-over-year.
- DiaMedica Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 52.42M shares, a 22.45% increase year-over-year.
- DiaMedica Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 49.63M shares, a 16.09% increase year-over-year.
- DiaMedica Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 46.98M shares, a 16.28% increase from fiscal 2024.
- DiaMedica Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 40.40M shares, a 24.07% increase from fiscal 2023.
- DiaMedica Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 32.57M shares, a 23.16% increase from fiscal 2022.
- DiaMedica Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 26.44M shares, a 27.29% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 53.89M shares 10-Q · filed 2026-08-10 | 53.84M shares 10-Q · filed 2026-08-10 | 53.37M shares derived: average of 3 quarters · filed 2026-08-10 | 52.43M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 53.79M shares 10-Q · filed 2026-05-06 | 53.11M shares derived: average of 2 quarters · filed 2026-05-06 | 51.95M shares derived: average of 3 quarters · filed 2026-05-06 | 49.70M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | 52.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 51.02M shares derived: average of 2 quarters · filed 2026-03-30 | 48.33M shares derived: average of 3 quarters · filed 2026-08-10 | 46.98M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 49.63M shares 10-Q · filed 2025-11-12 | 46.29M shares derived: average of 2 quarters · filed 2026-08-10 | 45.17M shares 10-Q · filed 2025-11-12 | 44.56M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | 42.96M shares 10-Q · filed 2026-08-10 | 42.90M shares 10-Q · filed 2026-08-10 | 42.87M shares derived: average of 3 quarters · filed 2026-08-10 | 42.84M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | 42.84M shares 10-Q · filed 2026-05-06 | 42.83M shares derived: average of 2 quarters · filed 2026-05-06 | 42.80M shares derived: average of 3 quarters · filed 2026-05-06 | 41.62M shares derived: average of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | 42.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 42.78M shares derived: average of 2 quarters · filed 2026-03-30 | 41.21M shares derived: average of 3 quarters · filed 2026-03-30 | 40.40M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 42.75M shares 10-Q · filed 2025-11-12 | 40.41M shares derived: average of 2 quarters · filed 2025-11-12 | 39.60M shares 10-Q · filed 2025-11-12 | 39.20M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 38.07M shares 10-Q · filed 2025-08-12 | 38.01M shares 10-Q · filed 2025-08-12 | 38.01M shares derived: average of 3 quarters · filed 2025-08-12 | 38.00M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 37.96M shares 10-Q · filed 2025-05-13 | 37.99M shares derived: average of 2 quarters · filed 2025-05-13 | 37.97M shares derived: average of 3 quarters · filed 2025-05-13 | 35.31M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 38.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 37.98M shares derived: average of 2 quarters · filed 2025-03-17 | 34.42M shares derived: average of 3 quarters · filed 2025-03-17 | 32.57M shares 10-K · filed 2025-03-17 |
| 2023-09-30 | 37.95M shares 10-Q · filed 2024-11-13 | 32.63M shares derived: average of 2 quarters · filed 2024-11-13 | 30.75M shares 10-Q · filed 2024-11-13 | 29.54M shares derived: average of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | 27.31M shares 10-Q · filed 2024-08-07 | 26.88M shares 10-Q · filed 2024-08-07 | 26.73M shares derived: average of 3 quarters · filed 2024-08-07 | 26.66M shares derived: average of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | 26.45M shares 10-Q · filed 2024-05-08 | 26.45M shares derived: average of 2 quarters · filed 2024-05-08 | 26.45M shares derived: average of 3 quarters · filed 2024-05-08 | 26.44M shares derived: average of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | 26.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | 26.44M shares derived: average of 2 quarters · filed 2024-03-19 | 26.44M shares derived: average of 3 quarters · filed 2024-03-19 | 26.44M shares 10-K · filed 2024-03-19 |
| 2022-09-30 | 26.44M shares 10-Q · filed 2023-11-13 | 26.44M shares derived: average of 2 quarters · filed 2023-11-13 | 26.44M shares 10-Q · filed 2023-11-13 | 26.46M shares derived: average of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | 26.44M shares 10-Q · filed 2023-08-14 | 26.44M shares 10-Q · filed 2023-08-14 | 26.46M shares derived: average of 3 quarters · filed 2023-08-14 | 24.61M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | 26.44M shares 10-Q · filed 2023-05-15 | 26.47M shares derived: average of 2 quarters · filed 2023-05-15 | 23.99M shares derived: average of 3 quarters · filed 2023-05-15 | 22.69M shares derived: average of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 26.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | 22.77M shares derived: average of 2 quarters · filed 2023-03-28 | 21.44M shares derived: average of 3 quarters · filed 2023-03-28 | 20.77M shares 10-K · filed 2023-03-28 |
| 2021-09-30 | 19.04M shares 10-Q · filed 2022-11-09 | 18.91M shares derived: average of 2 quarters · filed 2022-11-09 | 18.86M shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 18.79M shares 10-Q · filed 2022-08-11 | 18.78M shares 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | 18.77M shares 10-Q · filed 2022-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |